(Rac) -Norcantharidin

(Rac) -Norcantharidin ((Rac) -NCTD) is the racemic form of Norcantharidin. Norcantharidin is a demethylated derivative of Cantharidin (HY-N0209) and has antitumor activity[1][2][3].

Product Specifications

CAS Number

[5442-12-6]

Product Name Alternative

(Rac) -NCTD

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Apoptosis

Type

Natural Products

Related Pathways

Apoptosis

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/norcantharidin.html

Concentration

10mM

Purity

99.59

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C1OC(C2C(O3)CCC3C21)=O

Molecular Formula

C8H8O4

Molecular Weight

168.15

Precautions

H315, H319, H335

References & Citations

[1]Pan MS, et al. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chin Med. 2020 May 29;15:55.|[2]Zhou J, et al. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years. Biomed Pharmacother. 2020 Nov;131:110755.|[3]Zhang YY, et al. Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer. Arch Biochem Biophys. 2025 Sep;771:110510.